Summit Global Investments’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Summit Global Investments's IDXX Position: Q1 2025 in Review
Summit Global Investments sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 2,439 shares — an estimated $1.01M sold.
Summit Global Investments first reported a position in IDXX in Q2 2018 and held it in 22 quarters. The position peaked at $31.8M in Q4 2020. 1,143 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.
- Summit Global Investments reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
- Summit Global Investments sold 2,439 Idexx Laboratories shares in Q1 2025, an estimated $1.01M.
- Summit Global Investments first reported a position in Idexx Laboratories in Q2 2018 and held it in 22 quarters.
- Summit Global Investments's Idexx Laboratories position peaked at $31.8M in Q4 2020.
- 1,143 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.
Based on Summit Global Investments's 13F filing for Q1 2025, filed 7 Apr 2025.